Cosentyx UnoReady 300 mg / 2 ml, Injektionslösung im Fertigpen

7680683240011 CH-68324 Injektionslösung im Fertigpen
Cosentyx UnoReady 300 mg / 2 ml, Injektionslösung im Fertigpen
Cosentyx UnoReady 300 mg / 2 ml, Injektionslösung im Fertigpen
Cosentyx UnoReady 300 mg / 2 ml, Injektionslösung im Fertigpen
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Injektor(en), vorgefüllt/Pen
Galenic form
Injektionslösung im Fertigpen
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
28/05/2025
Patient information leaflet
Français
28/05/2025
Patient information leaflet
Italien
28/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
300.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 1185.10
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2022

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
68324
Drug name
Cosentyx UnoReady, Injektionslösung im Fertigpen
Galenic form
INLFP
ATC Code
L04AC10
Authorization status
Z
Dispensing category
B
First authorization
03/02/2022
Authorization expiration date
02/02/2027
IT Number
07.15.0.
Domain
Human medicine
Field of application
Plaque Psoriasis bei Erwachsenen, psoriatische Arthritis, Hidradenitis suppurativa

Package details

Description (FR)
COSENTYX UnoReady sol inj 300 mg/2ml stylo pré
Description (DE)
COSENTYX UnoReady Inj Lös 300 mg/2ml Fertpen
Market launch
03/02/2022
Narcotic (BTM)
No